Ebola Virus

Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates.
What is Ebola?

Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates. The natural reservoir of Ebola virus remains unknown, although bats seem to be the most likely reservoir.

Read More

Overview

Feature Articles

Latest Ebola Virus News and Research

International scientific team reports 'super-spreader' potential of Andes virus

International scientific team reports 'super-spreader' potential of Andes virus

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

New method helps detect remission points of pandemics

New method helps detect remission points of pandemics

Ebola virus antibodies found in people prior to 2018 DRC outbreak

Ebola virus antibodies found in people prior to 2018 DRC outbreak

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Research shows how remdesivir inhibits SARS-CoV-2 replication

Research shows how remdesivir inhibits SARS-CoV-2 replication

Researchers present COVID RdRp structure at 2.5A

Researchers present COVID RdRp structure at 2.5A

Scientists investigate pathogen transmission and awareness of common wildlife-associated zoonoses

Scientists investigate pathogen transmission and awareness of common wildlife-associated zoonoses

Study shows ssRNA encapsidation results in stabilization of the Ebola virus nucleocapsid

Study shows ssRNA encapsidation results in stabilization of the Ebola virus nucleocapsid

Researchers use supercomputers to simulate the inner working of Ebola virus

Researchers use supercomputers to simulate the inner working of Ebola virus

FDA approves Regeneron antibody drug as first treatment for Ebola virus

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Research elucidates the molecular mechanism of lentiviral cross-species transmission

Research elucidates the molecular mechanism of lentiviral cross-species transmission

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Self-isolation on arrival at airports dramatically improves detection of disease importation

Self-isolation on arrival at airports dramatically improves detection of disease importation

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

Study suggests a wider distribution range of Ebola virus carriers in Africa than previously assumed

Study suggests a wider distribution range of Ebola virus carriers in Africa than previously assumed

New cellular pathway protects cells from infection by Ebola virus, coronaviruses

New cellular pathway protects cells from infection by Ebola virus, coronaviruses